Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2022 Earnings Conference Call February 21, 2023 8:00 AM ET

Company Participants

Tiffany Aldrich - Associate Director, Corporate Communications

Sheldon Koenig - President and Chief Executive Officer

JoAnne Foody - Chief Medical Officer

Benjamin Halladay - CFO

Eric Warren - Chief Commercial Officer

Conference Call Participants

Serge Belanger - Needham

Joseph Thome - Cowen

Michael Yee - Jefferies

Jason Butler - JMP Securities

Jeff Hung - Morgan Stanley

Tom Shrader - BTIG

Jessica Fye - JPMorgan

Judah Frommer - Credit Suisse

Paul Choi - Goldman Sachs

Operator

Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today's conference call may be recorded.

I would now like to hand the conference over to Tiffany Aldrich, Associate Director, Corporate Communications at Esperion. Please go ahead, Tiffany.

Tiffany Aldrich

Thank you. Good morning, and welcome to Esperion's fourth quarter and full year 2022 financial results and company update conference call. I'm Tiffany Aldrich, and I'm part of Corporate Communications here at Esperion. I want to remind callers that the information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the business.

These forward-looking statements are qualified in their entirety by the cautionary statements contained in today's press release and our SEC filings. The content of this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, February 21, 2023. We undertake no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call and webcast.

As a reminder, this conference call and webcast are being recorded and archived. We issued a press release this morning detailing the content of today's call. A copy can be found at www.esperion.com within the Investors and Media section.

We will begin with prepared comments and then open the call for your questions. Following today's call, the team will be available for follow-up questions. Please e-mail corporate team at esperion.com to schedule time to speak with the team.

With us today are Sheldon Koenig, President and CEO; Dr. JoAnne Foody, Chief Medical Officer; Ben Halladay, Chief Financial Officer; Eric Warren, Chief Commercial Officer; and BJ Swartz, Chief Strategy Officer.